pubmed:abstractText |
The Humana Hospital, a 356-bed facility, set up a drug use evaluation (DUE) program to monitor the administration of products containing acetaminophen (APAP), to observe the extent of overdosing of APAP products, and to educate and resolve the problems. The DUE originated in the OB/GYN unit and then was expanded to all hospital units. The study methods and the process used to resolve noncompliance with recommended dosing guidelines are presented below.
|